文献速递乳腺技术与安全US

低功率超声微泡改善三阴性乳腺癌微环境与药物递送

Low-Power Ultrasound With Microbubbles Improve Oxygenation and Doxorubicin Uptake in Hypoxic Triple-Negative Breast Cancer.
PubMed 文献 · J Ultrasound Med · 2026-01-17

本研究在4T1小鼠三阴性乳腺癌模型中评估低功率超声微泡治疗对肿瘤灌注、氧合及药物摄取的影响。联合增强超声、超分辨显微成像和光声成像显示,超声微泡治疗后肿瘤灌注和氧合显著改善,阿霉素浓度较化疗组提高3.15倍。阻断eNOS/NO通路后灌注增强效应显著减弱,提示NO信号在该效应中发挥关键作用。

要点

  • 超声微泡治疗可改善三阴性乳腺癌肿瘤血管灌注和氧合状态。
  • 超声微泡联合化疗可显著提高肿瘤内阿霉素浓度和分布范围。
  • eNOS/NO信号通路是超声微泡增强肿瘤灌注的关键介导机制。

核心结论

  • 超声微泡通过NO信号通路促进肿瘤灌注和氧合,显著增强三阴性乳腺癌的药物递送效率。

研究设计与样本

  • 动物实验研究,采用4T1小鼠三阴性乳腺癌模型评估超声微泡治疗疗效。
  • 联合应用增强超声(CEUS)、超分辨显微成像(URM)和光声成像(PAI)评估肿瘤状态。
  • 采用高效液相色谱(HPLC)和CD31免疫荧光共聚焦显微镜定量分析药物渗透和分布。
  • 通过一氧化氮抑制实验验证内皮型一氧化氮合酶/一氧化氮(eNOS/NO)通路的参与。

关键影像表现/征象

  • 超声微泡治疗后4小时内肿瘤灌注显著增加(P < .001),灌注不足区域减少,氧合水平升至基线的1.4倍。
  • 超声微泡组的阿霉素浓度为化疗组的3.15倍,且瘤内分布范围更广。

诊断标准与关键数值

  • 肿瘤灌注在治疗后4小时内显著增加(P < .001)。
  • 氧合水平升高至基线的1.4倍。
  • 超声微泡组阿霉素浓度为化疗组的3.15倍。
  • 阻断eNOS/NO信号后超声微泡的灌注增强效应显著减弱。

临床应用与阅片要点

  • 超声微泡可能作为三阴性乳腺癌联合治疗的辅助策略,以增强化疗药物递送。
  • 临床转化中可关注eNOS/NO通路作为潜在的联合治疗靶点。

局限性

  • 本研究为动物模型研究,尚未在人体中验证超声微泡治疗的安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Triple-negative breast cancer (TNBC) exhibits poor chemotherapy response and prognosis due to the lack of targeted therapies and a hypoxic, poorly vascularized tumor microenvironment. This study demonstrated the efficacy of low-power ultrasound-stimulated microbubble (USMB) therapy in enhancing drug delivery and improving the TNBC microenvironment, with a focus on its relationship with nitric oxide (NO).

METHODS: A 4T1 murine TNBC model was established. Multi-parametric imaging techniques, including contrast-enhanced ultrasound (CEUS), ultra-resolution microscopy imaging (URM), and photoacoustic imaging (PAI) were innovatively combined to assess tumor perfusion, oxygenation, and drug delivery following USMB treatment. Epirubicin penetration and targeted intratumoral distribution were quantitatively analyzed using high-performance liquid chromatography (HPLC) and CD31 immunofluorescence under confocal microscopy. NO inhibition experiments were conducted to evaluate the involvement of the endothelial NO synthase (eNOS)/NO pathway.

RESULTS: Group USMB significantly increased tumor perfusion within 4 hours post-treatment (p < .001), reduced perfusion-deficient regions, and raised oxygenation to 1.4-fold of baseline. Doxorubicin (Dox) concentration was 3.15-fold higher than the chemotherapy group, with wider distribution. Blocking eNOS/NO signaling markedly attenuated the perfusion-enhancing effects of USMB, implicating NO as a key mediator.

CONCLUSION: USMB improves the TNBC microenvironment and enhances drug delivery by promoting perfusion and oxygenation, likely via NO signaling. These findings support USMB as a promising strategy for TNBC combination therapy and highlight NO as a potential therapeutic target.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Zhang, Huang, Zhao, et al. Low-Power Ultrasound With Microbubbles Improve Oxygenation and Doxorubicin Uptake in Hypoxic Triple-Negative Breast Cancer. J Ultrasound Med. 2026. PMID: 41546679. doi:10.1002/jum.70174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。